On June 11, Glooko and the Joslin Diabetes Center announced the release of their HypoMap software , a cool product that really should be able to identify and help...

The Centers for Disease Control (CDC) has released its new data on the state of diabetes in the United States, providing an update on its 2011 National Diabetes Fact...

Twitter summary: Exciting positive vote for #liraglutide #emdac on possible new therapy for #obesity! Plus, our favorite open public hearing yet. Yesterday on September...

(S)he said what?!?

Why 2015 may be the “tipping point” for digital therapies in diabetes.

How a dramatic 23% increase in new diabetes cases impacts people living with diabetes nationwide.

Starting in 2012, the American Diabetes Association established the Pathway to Stop Diabetes initiative, a $1.6 million grant (paid over five years) to support the...

The latest on Medtronic’s drive to close the loop!

Can a drug long-used to treat gout be effective at preventing diabetic kidney disease?

How this “disease interception” strategy could transform our knowledge of type 1 diabetes.

Expansion of the use of Roche’s Lucentis a major step for patients.

How a single change at the FDA could lead to major improvements for patients and the healthcare system.

Leading ophthalmologist Dr. Ivan Suñer on what diabetic retinopathy is, how to prevent it, and what future treatments hold.

Praluent now approved for two specific patient populations. How this drug has the future potential to make a big impact on people with diabetes.

What does this controversial data mean for the type 2 diabetes epidemic?

Our top actionable tips for parents: straight from Friends for Life!

ADA, CDC, AMA, and the Ad Council just launched the first-ever national PSA campaign targeting prediabetes awareness and prevention - plus, three short video ads!

Diagnoses stabilizing, though 83% of 65+ year olds have diabetes or prediabetes.

Leaders in diabetes weigh in at The diaTribe Foundation’s second-annual event in Europe.

Gamechanging Xultophy (Tresiba + Victoza) also now submitted to the FDA.